Current management of non‐amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes

Documenti analoghi

• Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14‐Year Experience of an Academic Center
  di: Danai Dima, et al.
  Pubblicazione: (2025)
• Cytogenetic abnormality in non‐systemic light chain amyloidosis monoclonal gammopathy of renal significance: A field needs to be explored
  di: Xianghua Huang
  Pubblicazione: (2024)
• Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate Correlation
  di: David Kaplan, et al.
  Pubblicazione: (2025)
• Molecular Expression Differences in Specific Blood Mononuclear Cell‐Types Identify Patients With AL Amyloidosis
  di: David Kaplan, et al.
  Pubblicazione: (2025)
• Evaluating ChatGPT as an educational resource for patients with multiple myeloma: A preliminary investigation
  di: Ludovic Saba, et al.
  Pubblicazione: (2024)